Amgen wants in on the booming weight loss drug market — and it’s taking a different approach
Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after
Read MoreAmgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after
Read MoreSome patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly
Read MoreFalling fertility rates are set to spark a transformational demographic shift, with big implications for the global economy, according to
Read MoreMedicare patients can soon get coverage for Novo Nordisk's Wegovy as long as it is prescribed to reduce their risk
Read MoreDrugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI
Read MoreJohnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery. Source link
Read MoreUnitedHealth Group said it's paid out more than $2 billion in advances to help health-care providers deal with the fallout
Read MoreAmbient clinical documentation was the talk of the HIMSS conference in Orlando, Florida, this year. Source link
Read MoreSome health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read More